论文部分内容阅读
老年性慢性支气管炎(下简称老慢支)是目前我国老年呼吸道感染中最常见疾病。严重影响老年人身体健康及生命质量。对于老慢支治疗,常以抗生素为主要手段。随着近几年来抗生素不断更新换代,用量不断增加,耐药菌株也相继产生。要防止和减少致病菌耐药性增强,必须掌握老慢支感染的致病菌及其对抗药物敏感性的流行病学资料,建立合理用药制度。这对于选择抗菌药物以提高临床疗效,保护人体微生态平衡都具有重要意义。由于近五年来本院大量新抗生素应用,该病患者感染病原茵及耐药情况亦发生很大变化。
Senile chronic bronchitis (hereinafter referred to as the old chronic bronchitis) is the most common diseases in elderly respiratory tract infections in our country. Seriously affect the health and quality of life of the elderly. For the old chronic bronchitis treatment, often with antibiotics as the main means. With the continuous upgrading of antibiotics in recent years, increasing dosage, resistant strains have also been produced. To prevent and reduce pathogenic bacteria increased resistance, we must master the chronic bronchitis infection pathogens and their anti-drug susceptibility epidemiological data to establish a reasonable drug system. This is of great importance for the choice of antimicrobial agents to improve clinical efficacy and protect the body’s micro-ecological balance. Due to the large number of new antibiotics used in our hospital in the recent five years, the disease infected with pathogens and drug resistance have also undergone great changes.